Author Correction: NICE’s rejection of pembrolizumab for platinum-refractory urothelial carcinoma: is there a greater good?

Detalles Bibliográficos
Autores principales: Gupta, Shilpa, Kamat, Ashish M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Author Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608133/
https://www.ncbi.nlm.nih.gov/pubmed/32719534
http://dx.doi.org/10.1038/s41585-020-0361-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608133/
https://www.ncbi.nlm.nih.gov/pubmed/32719534
http://dx.doi.org/10.1038/s41585-020-0361-5

Ejemplares similares